PharmiWeb.com - Global Pharma News & Resources

Press Releases - 2019-08-07

Date Title Company
07-Aug-2019 First-Ever 36 Month Real-World, Post-Marketing Surveillance Study Confirms The Excellent Safety And Tolerability Profile Of IBgard®, A Non-Prescription Product For IBS IM HealthScience
07-Aug-2019 Natera Reports Second Quarter 2019 Financial Results Natera, Inc.
07-Aug-2019 Portola Pharmaceuticals Reports Second Quarter 2019 Financial Results and Provides Corporate Update Portola Pharmaceuticals, Inc.
07-Aug-2019 Syndax Pharmaceuticals Reports Second Quarter 2019 Financial Results and Provides Clinical and Business Update Syndax Pharmaceuticals, Inc.
07-Aug-2019 Syndax Pharmaceuticals Reports Second Quarter 2019 Financial Results and Provides Clinical and Business Update Syndax Pharmaceuticals, Inc.
07-Aug-2019 REGENXBIO Reports Second Quarter 2019 Financial and Operating Results and Additional Positive Interim Phase I/IIa Trial Update for RGX-314 for the Treatment of Wet AMD REGENXBIO Inc.
07-Aug-2019 Proteostasis Therapeutics Reports Second Quarter 2019 Financial Results and Provides Corporate Update Proteostasis Therapeutics, Inc.
07-Aug-2019 Arena Reports Second Quarter Financial Results with Strong Liquidity Position, and Initiation of Etrasimod ELEVATE UC 52 and Olorinab CAPTIVATE Trials Arena Pharmaceuticals, Inc.
07-Aug-2019 BOOTS UK PILOTS NEW IN-STORE INTERPRETATION SERVICE Boots UK
07-Aug-2019 Heart-on-a-Chip Mimics Drug Response Seen in Humans TARA Biosystems, Inc.
07-Aug-2019 Biom'up issues a new tranche of EUR 5 million from the credit line granted by Athyrium Biom'up
07-Aug-2019 DiscGenics Announces First Patients Treated in Japanese Clinical Trial of Cell Therapy for Degenerative Disc Disease DiscGenics, Inc.
07-Aug-2019 EVOTEC SE TO REPORT FIRST HALF-YEAR 2019 RESULTS ON 14 AUGUST 2019 Evotec SE
07-Aug-2019 TopiVert Announces Top-Line Results from THEIA-1 Phase 2b/3 Clinical Study of TOP1630 as a Treatment for Dry Eye Disease TopiVert
07-Aug-2019 Lynparza Phase III PROfound trial in HRR* mutation-selected metastatic castration-resistant prostate cancer met primary endpoint AstraZeneca and MSD
07-Aug-2019 Elite Pharmaceuticals, Inc. to Host Conference Call to Provide Corporate Update and Discuss First Quarter 2020 Financial Results on August 12, 2019 Elite Pharmaceuticals, Inc.
07-Aug-2019 Chad Finney Joins Pilatus Comparator Solutions as VP, North America Pilatus Comparator Solutions
07-Aug-2019 Chad Finney Joins Pilatus Comparator Solutions as VP, North America Pilatus Comparator Solutions
07-Aug-2019 Lilly Announces Leadership Changes in Corporate Business Development, Oncology R&D, and Managed Healthcare Services Eli Lilly and Company
07-Aug-2019 Global Track And Trace Solutions Market Forthcoming Opportunities, Challenges | Value At US$ 2 Bn in 2019 Wired Release